US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties

By Karen Freifeld (Reuters) -A new version of a congressional bill that would restrict U.S. business with certain Chinese biotechnology companies including WuXi AppTec and BGI would give U.S. companies until 2032 to end work with the firms, extending the amount of time to find new partners. The latest Biosecure Act also adds WuXi Biologics…

Read More